EGR2 Gene CMT1D Genetic Test
Test Name: EGR2 Gene CMT1D Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for EGR2 Gene CMT1D NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT1D.
Test Details
The EGR2 gene is associated with Charcot-Marie-Tooth disease type 1D (CMT1D), a genetic disorder that affects the peripheral nerves. The EGR2 gene provides instructions for making a protein called early growth response 2, which plays a role in the development and maintenance of the myelin sheath that surrounds and protects nerve fibers.
NGS (next-generation sequencing) genetic testing can be used to analyze the DNA sequence of the EGR2 gene and identify any mutations or variations that may be responsible for CMT1D. This type of genetic testing can help diagnose the condition and provide information about the inheritance pattern and risk of passing the condition on to future generations.
NGS genetic testing for CMT1D typically involves collecting a sample of DNA from the patient, which can be obtained through a blood sample or a cheek swab. The DNA is then analyzed using specialized sequencing technology to identify any mutations or variations in the EGR2 gene.
Results of the NGS genetic test can help healthcare providers develop an appropriate treatment plan for individuals with CMT1D and provide genetic counseling to affected individuals and their families.
| Test Name | EGR2 Gene CMT1D Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for EGR2 Gene CMT1D NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT1D |
| Test Details |
The EGR2 gene is associated with Charcot-Marie-Tooth disease type 1D (CMT1D), a genetic disorder that affects the peripheral nerves. The EGR2 gene provides instructions for making a protein called early growth response 2, which plays a role in the development and maintenance of the myelin sheath that surrounds and protects nerve fibers. NGS (next-generation sequencing) genetic testing can be used to analyze the DNA sequence of the EGR2 gene and identify any mutations or variations that may be responsible for CMT1D. This type of genetic testing can help diagnose the condition and provide information about the inheritance pattern and risk of passing the condition on to future generations. NGS genetic testing for CMT1D typically involves collecting a sample of DNA from the patient, which can be obtained through a blood sample or a cheek swab. The DNA is then analyzed using specialized sequencing technology to identify any mutations or variations in the EGR2 gene. Results of the NGS genetic test can help healthcare providers develop an appropriate treatment plan for individuals with CMT1D and provide genetic counseling to affected individuals and their families. |
